The mean of analysts' price targets for Monopar Therapeutics (MNPR) points to a 51.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's What You Should Know

Does Perrigo (PRGO) Have the Potential to Rally 32.86% as Wall Street Analysts Expect? — Positive

PRGO   Zacks Investment Research — June 11, 2025

The consensus price target hints at a 32.9% upside potential for Perrigo (PRGO). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Does Perrigo (PRGO) Have the Potential to Rally 32.86% as Wall Street Analysts Expect?

Wall Street Analysts Predict a 25.9% Upside in Veris (VRE): Here's What You Should Know — Positive

VRE   Zacks Investment Research — June 11, 2025

The average of price targets set by Wall Street analysts indicates a potential upside of 25.9% in Veris (VRE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

image for news Wall Street Analysts Predict a 25.9% Upside in Veris (VRE): Here's What You Should Know

Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect? — Positive

GKOS   Zacks Investment Research — June 11, 2025

The mean of analysts' price targets for Glaukos (GKOS) points to a 34.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

image for news Can Glaukos (GKOS) Climb 34.4% to Reach the Level Wall Street Analysts Expect?

The consensus price target hints at a 26.8% upside potential for Byrna Technologies (BYRN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Predict a 26.78% Upside in Byrna Technologies (BYRN): Here's What You Should Know

The consensus price target hints at a 42.2% upside potential for Copa Holdings (CPA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Think Copa Holdings (CPA) Could Surge 42.18%: Read This Before Placing a Bet

The consensus price target hints at a 39.6% upside potential for FuelCell Energy (FCEL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

image for news Wall Street Analysts Believe FuelCell Energy (FCEL) Could Rally 39.58%: Here's is How to Trade

How ExxonMobil's Upstream Business is Coping With Falling Oil Prices — Neutral

XOM   Zacks Investment Research — June 11, 2025

XOM's upstream profits face pressure from falling oil prices, but its low Permian breakeven costs offer a key buffer.

image for news How ExxonMobil's Upstream Business is Coping With Falling Oil Prices

Blackstone Plans to Invest $500 Billion in Europe Over 10 Years — Positive

BX   Zacks Investment Research — June 11, 2025

BX plans to pour $500 billion into Europe over 10 years, eyeing growth as the region boosts spending and reforms take shape.

image for news Blackstone Plans to Invest $500 Billion in Europe Over 10 Years

NVO Stock Gains After Parvus Asset Management Builds Stake — Positive

NVO   Zacks Investment Research — June 11, 2025

Novo Nordisk jumps 5% as Parvus Asset Management builds a stake to sway CEO succession amid leadership shakeup and pipeline buzz.

image for news NVO Stock Gains After Parvus Asset Management Builds Stake

S&P 500 ETFs Near Record Highs: More Upside in Store? — Positive

IVV  SPY  VOO   Zacks Investment Research — June 11, 2025

SPY nears record highs as AI momentum, resilient earnings and trade optimism fuel a 20% S&P 500 rebound.

image for news S&P 500 ETFs Near Record Highs: More Upside in Store?

Best Momentum Stocks to Buy for June 11th — Positive

BAESY  SSRM  VEEV   Zacks Investment Research — June 11, 2025

SSRM, VEEV and BAESY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 11, 2025.

image for news Best Momentum Stocks to Buy for June 11th

Pick and Place Friendly Lead Bending Option Allows Devices to Be Used as SMD Components to Reduce Assembly Costs Pick and Place Friendly Lead Bending Option Allows Devices to Be Used as SMD Components to Reduce Assembly Costs

image for news Vishay Intertechnology AC03-CS Series Axial Cemented, Leaded Wirewound Safety Resistors Now Available With WSZ Lead Form

DOVER, Del.--(BUSINESS WIRE)--Nautilus Solar Energy, LLC (“Nautilus”) and TurningPoint Energy (“TPE”) celebrated their collaboration on a new 4.7-megawatt direct current (MWdc) solar farm in Georgetown, Delaware on June 10, 2025, with a ribbon cutting event at the project site. The array is made up of nearly 9,000 solar modules and is part of a six-project, 30MWdc portfolio that has been developed by TPE and being built and operated by Nautilus. Distinguished guests, as well as executives from.

image for news Powering up Delaware: Nautilus Solar Energy and TurningPoint Energy Launch One of the First Solar Farms in Major Renewable Energy Portfolio

Abbie and Glen Warren, Daniel Lauper and Peter O'Brien recognized for their dedication to building safer, stronger and more compassionate communities Abbie and Glen Warren, Daniel Lauper and Peter O'Brien recognized for their dedication to building safer, stronger and more compassionate communities

image for news Direct Energy Honours Alberta Community Heroes through Volunteer Citizen of the Year Award

SINGAPORE--(BUSINESS WIRE)--A high-profile seminar titled “From Investment to Residency: New Zealand's Active Investor Plus Visa” was held today in Singapore, bringing together high-net-worth individuals exploring residency through New Zealand's Active Investor Plus (AIP) visa program. The exclusive, invite-only event was delivered by Greener Pastures New Zealand, ANZ Migrate, and St. James' Place, the three firms at the forefront of investment migration and wealth advisory. The strong turnout.

image for news High-Profile Seminar at New Zealand High Commission Highlights Rising Demand for AIP Visa Pathway Among Global Investors

Designer Brands: No Turnaround In Sight (Rating Downgrade) — Negative

DBI   Seeking Alpha — June 11, 2025

Designer Brands Inc. faces a systemic demand collapse, with declining sales, eroding margins, and mounting debt signaling a failing retail model. Consumer behavior has fundamentally shifted, with nearly 80% skipping shoe purchases and 60% only buying on sale, destroying DBI's pricing power. Cost-cutting and operational improvements offer minor relief, but are overwhelmed by macro headwinds, tariff pressures, and a deteriorating cash flow profile.

image for news Designer Brands: No Turnaround In Sight (Rating Downgrade)

General Mills weighs sale of Häagen-Dazs stores in China: report — Neutral

GIS   Proactive Investors — June 11, 2025

General Mills Inc (NYSE:GIS, ETR:GRM) is considering the sale of its Häagen-Dazs ice cream stores in China, according to a report from Bloomberg News. The publication, citing sources with knowledge of the matter, said the Minneapolis-based company may seek several hundred million dollars for these assets.

image for news General Mills weighs sale of Häagen-Dazs stores in China: report

Here's Why HealthEquity (HQY) is a Strong Momentum Stock — Positive

HQY   Zacks Investment Research — June 11, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Here's Why HealthEquity (HQY) is a Strong Momentum Stock

Why Johnson & Johnson (JNJ) is a Top Momentum Stock for the Long-Term — Positive

JNJ   Zacks Investment Research — June 11, 2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

image for news Why Johnson & Johnson (JNJ) is a Top Momentum Stock for the Long-Term